Date Filed | Type | Description |
07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2023 |
4
| Skycrest Holdings, LLC (10% Owner) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Bought 400,000 shares
@ $0.009, valued at
$3.6k
Bought 200,000 shares
@ $0.009, valued at
$1.8k
|
|
06/30/2023 |
4
| Leider Harry L. (CEO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Bought 549,450 shares
@ $0.099, valued at
$54.4k
Bought 500,000 shares
@ $0.01, valued at
$5k
|
|
06/28/2023 |
4
| Skycrest Holdings, LLC (10% Owner) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Bought 800,000 shares
@ $0.009, valued at
$7.2k
|
|
06/09/2023 |
3
| Golub Howard Lawrence (Executive Vice President & CSO) has filed a Form 3 on Organicell Regenerative Medicine, Inc. |
06/09/2023 |
3
| Leider Harry L. (CEO and Director) has filed a Form 3 on Organicell Regenerative Medicine, Inc. |
12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/03/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/27/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/17/2022 |
4
| Sinnreich Matthew Phillip (President and Acting CEO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Sold 20,000 shares
@ $0.04, valued at
$800 |
|
10/11/2022 |
3
| CHISTE JOHN F (Director) has filed a Form 3 on Organicell Regenerative Medicine, Inc. |
10/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/29/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/20/2022 |
3
| Likes Ryan C (COO) has filed a Form 3 on Organicell Regenerative Medicine, Inc. |
09/16/2022 |
3
| Grey Wendy (10% Owner) has filed a Form 3 on Organicell Regenerative Medicine, Inc. |
08/24/2022 |
4
| Carbonara Michael (Director) has filed a Form 4 on Organicell Regenerative Medicine, Inc. |
08/24/2022 |
4
| Meglin Allen James (Director) has filed a Form 4 on Organicell Regenerative Medicine, Inc. |
08/24/2022 |
4
| Shapiro George Craig (Chief Medical Officer) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Granted 3,150,000 options to buy
@ $0.02, valued at
$63k
|
|
08/24/2022 |
4
| BOTHWELL IAN T (CFO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Granted 30,000,000 options to buy
@ $0.02, valued at
$600k
|
|
07/26/2022 |
3
| Sinnreich Matthew Phillip (COO and Acting CEO) has filed a Form 3 on Organicell Regenerative Medicine, Inc. |
11/02/2021 |
4
| Mitrani Albert (CEO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Disposed of 15,000,000 shares
@ $0 Acquired 15,000,000 shares
@ $0 |
|
11/02/2021 |
4
| MITRANI MARIA INES (Chief Science Officer) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Disposed of 15,000,000 shares
@ $0 Acquired 15,000,000 shares
@ $0 |
|
11/02/2021 |
4
| Shapiro George Craig (Chief Medical Officer) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Disposed of 5,000,000 shares
@ $0 Acquired 5,000,000 shares
@ $0 |
|
11/02/2021 |
4
| BOTHWELL IAN T (CFO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Disposed of 15,000,000 shares
@ $0 Acquired 15,000,000 shares
@ $0 |
|
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2021 |
4
| MITRANI MARIA INES (Chief Science Officer) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Sold 5,228 shares
@ $0.14, valued at
$731.9 Sold 44,772 shares
@ $0.138, valued at
$6.2k
|
|
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2021 |
4
| Mitrani Albert (President) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Sold 50,000 shares
@ $0.14, valued at
$7k
|
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| MITRANI MARIA INES (Chief Science Officer) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns:
| Sold 50,000 shares
@ $0.14, valued at
$7k
Sold 50,000 shares
@ $0.16, valued at
$8k
Sold 50,000 shares
@ $0.161, valued at
$8.1k
|
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|